Neurol. praxi. 2023;24(4):268-273 | DOI: 10.36290/neu.2023.056

Post­‑stroke epilepsy

MUDr. Eva Zatloukalová
I. neurologická klinika Fakultní nemocnice u sv. Anny a LF MU Brno
Mezinárodní centrum klinického výzkumu (ICRC) Fakultní nemocnice u sv. Anny v Brně

How should be the post-stroke epilepsy diagnosed? What are the risks of developping this condition after the stroke? And finally, how should we treat this condition and what are the tricky aspects of it? Without this knowledge, it is impossible to treat post-stroke epilepsy effectively. Inappropriate treatment can bring unnecessary patient stigmatization and serious side effects. This review aimes to provide answers to these questions connected to the disease with raising prevalence bringing many risk to the patients.

Keywords: post-stroke epilepsy, acute symptomatic seizure, unprovoked seizure, antiseizure medication, continuous EEG.

Accepted: August 24, 2023; Published: September 8, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zatloukalová E. Post­‑stroke epilepsy. Neurol. praxi. 2023;24(4):268-273. doi: 10.36290/neu.2023.056.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alvarez­‑Sabín J, Montaner J, Padró L, et al. Gabapentin in late­‑onset poststroke seizures. Neurology. 2002;59(12): 1991-1993. Available from: https://doi.org/10.1212/01.wnl.0000038388.57824.b6. Go to original source... Go to PubMed...
    2. Apovian CM, Aronne LJ. Zonisamide for weight reduction in obese adults. JAMA. 2013;310(6):637-638. Available from: https://doi.org/10.1001/jama.2013.101049. Go to original source... Go to PubMed...
    3. Ashjazadeh N, Fathi M, Shariat A. Evaluation of Homocysteine Level as a Risk Factor among Patients with Ischemic Stroke and Its Subtypes. Iranian Journal of Medical Sciences. 2013;38(3):233-239.
    4. Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671-675. Available from: https://doi.org/10.1111/j.1528-1167.2009.02285.x. Go to original source... Go to PubMed...
    5. Beghi E, D'Alessandro R, Beretta S, et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology. 2011;77(20):1785-1793. Available from: https://doi.org/10.1212/WNL.0b013e3182364878. Go to original source... Go to PubMed...
    6. Belcastro V, Costa C, Galleli F, et al. Levetiracetam in newly diagnosed late­‑onset post­‑stroke seizures: A prospective observational study. Epilepsy Research. 2008;82(2-3):223-226. Available from: https://doi.org/10.1016/j.eplepsyres.2008. 08. 008. Go to original source... Go to PubMed...
    7. Belcastro V, Striato P, Gorgone G, et al. Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia. 2010;51(2):274-279. Available from: https://doi.org/10.1111/j.1528-1167.2009.02303.x. Go to original source... Go to PubMed...
    8. Bentes C, Rodrigues FB, Sousa D, et al. Frequency of post­‑stroke electroencephalographic epileptiform activity - a systematic review and meta­‑analysis of observational studies. European Stroke Journal. 2017;2(4):361-368. Available from: https://doi.org/10.1177/2396987317731004. Go to original source... Go to PubMed...
    9. Bentes C, Pimentel J, Ferro JM. Epileptic seizures following subcortical infarcts', Cerebrovascular Diseases (Basel, Switzerland). 2001;12(4):331-334. Available from: https://doi.org/10.1159/000047730. Go to original source... Go to PubMed...
    10. Biton V, Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy. CNS drugs. 2003;17(11):781-791. Available from: https://doi.org/10.2165/00023210-200317110-00002. Go to original source... Go to PubMed...
    11. Brigo F, Lattanzi F, Zelano J, et al. Randomized controlled trials of antiepileptic drugs for the treatment of post­‑stroke seizures: A systematic review with network meta­‑analysis. Seizure. 2018;61:57-62. Available at: https://doi.org/10.1016/j.seizure.2018. 08. 001. Go to original source... Go to PubMed...
    12. Burneo JG, Fang J, Saposik G, et al. Impact of seizures on morbidity and mortality after stroke: a Canadian multi­‑centre cohort study. European Journal of Neurology. 2010;17(1):52-58. Available from: https://doi.org/10.1111/j.1468-1331.2009.02739.x. Go to original source... Go to PubMed...
    13. Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke. 2004;35(7):1769-1775. Available from: https://doi.org/10.1161/01.STR.0000130989.17100. 96. Go to original source... Go to PubMed...
    14. Chuang YC, Chuang HY, Lin TK, et al. Effects of long­‑term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia. 2012;53(1):120-128. Available from: https://doi.org/10.1111/j.1528-1167.2011.03316.x. Go to original source... Go to PubMed...
    15. Conrad J, Pawlowski M, Dogan M, et al. Seizures after cerebrovascular events: risk factors and clinical features. Seizure. 2013;22(4):275-282. Available from: https://doi.org/10.1016/j.seizure.2013. 01. 014. Go to original source...
    16. Fisher RS, Acevedo C, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482. Available from: https://doi.org/10.1111/epi.12550. Go to original source... Go to PubMed...
    17. Forsgren L, Beghi E, Qun A, et al. The epidemiology of epilepsy in Europe - a systematic review. European Journal of Neurology. 2005;12(4):245-253. Available from: https://doi.org/10.1111/j.1468-1331.2004.00992.x. Go to original source... Go to PubMed...
    18. Galgani A, Palleria C, Iannone LF, et al. Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs. Frontiers in Neurology. 2018;9:1067. Available from: https://doi.org/10.3389/fneur.2018.01067. Go to original source... Go to PubMed...
    19. Galovic M, Döhler N, Erdélyi-Canavese B, et al. Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study. The Lancet. Neurology. 2018;17(2):143-152. Available from: https://doi.org/10.1016/S1474-4422(17)30404-0. Go to original source... Go to PubMed...
    20. Galovic M, Ferreira-Atuesta C, Abraira L, et al. Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management. Drugs & Aging. 2021;38(4):285-299. Available from: https://doi.org/10.1007/s40266-021-00837-7. Go to original source... Go to PubMed...
    21. Gilad R, Lompe Y, Eschel Y, et al. Antiepileptic treatment in patients with early postischemic stroke seizures: a retrospective study. Cerebrovascular Diseases (Basel, Switzerland). 2001;12(1):39-43. Available from: https://doi.org/10.1159/000047679. Go to original source... Go to PubMed...
    22. Graham NSN, Crichton S, Koubroumanidis M, et al. Incidence and associations of poststroke epilepsy: the prospective South London Stroke Register. Stroke. 2013;44(3):605-611. Available from: https://doi.org/10.1161/STROKEAHA.111.000220. Go to original source... Go to PubMed...
    23. Guo J, Guo J, Li J, et al. Statin treatment reduces the risk of poststroke seizures. Neurology. 2015;85(8):701-707. Available from: https://doi.org/10.1212/WNL.0000000000001814. Go to original source... Go to PubMed...
    24. Haapaniemi E, Strbian D, Rossi C, et al. The CAVE score for predicting late seizures after intracerebral hemorrhage. Stroke. 2014;45(7):1971-1976. Available from: https://doi.org/10.1161/STROKEAHA.114.004686. Go to original source... Go to PubMed...
    25. Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society. 2015;32(2):87-95. Available from: https://doi.org/10.1097/WNP.0000000000000166. Go to original source... Go to PubMed...
    26. Hesdorffer DC, Benn EKT, Cascino GD, et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009;50(5):1102-1108. Available from: https://doi.org/10.1111/j.1528-1167.2008.01945.x. Go to original source... Go to PubMed...
    27. Holtkamp M, Beghi E, Benninger F, et al. European Stroke Organisation guidelines for the management of post­‑stroke seizures and epilepsy. European Stroke Journal. 2017;2(2):103-115. Available from: https://doi.org/10.1177/2396987317705536. Go to original source... Go to PubMed...
    28. Huang CW, Saposnik G, Fang J, et al. Influence of seizures on stroke outcomes: a large multicenter study. Neurology. 2014;82(9):768-776. Available from: https://doi.org/10.1212/wnl.0000000000000166. Go to original source... Go to PubMed...
    29. Janousek J, Barber A, Goldman L, et al. Obesity in adults with epilepsy', Epilepsy & Behavior: E & B. 2013;28(3):391-394. Available from: https://doi.org/10.1016/j.yebeh.2013. 05. 012. Go to original source... Go to PubMed...
    30. Janský P, Růžičková T, Olšerová A, et al. Occurrence and risk factors of unprovoked epileptic seizures in ischaemic stroke patients. Česká a slovenská neurologie a neurochirurgie. 2020; 83/116(3):278-284. Available from: https://doi.org/10.14735/amcsnn2020278. Go to original source...
    31. Jung S, Schindler K, Findling O, et al. Adverse effect of early epileptic seizures in patients receiving endovascular therapy for acute stroke. Stroke. 2012;43(6):1584-1590. Available from: https://doi.org/10.1161/STROKEAHA.111.645358. Go to original source... Go to PubMed...
    32. Katsiki N, Mikhailidis DP, Nair Dr. The effects of antiepileptic drugs on vascular risk factors: a narrative review. Seizure. 2014;23(9):677-684. Available from: https://doi.org/10.1016/j.seizure.2014. 05. 011. Go to original source...
    33. Kutlu G, Gomceli YB, Yasemin U, et al. Levetiracetam monotherapy for late poststroke seizures in the elderly', Epilepsy & Behavior. 2008;13(3):542-544. Available from: https://doi.org/10.1016/j.yebeh.2008. 04. 025. Go to original source... Go to PubMed...
    34. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology. 2001;57(2):200-206. Available from: https://doi.org/10.1212/wnl.57. 2. 200. Go to original source... Go to PubMed...
    35. Lahti AM, Saloheimo P, Huhtakangos J, et al. Poststroke epilepsy in long­‑term survivors of primary intracerebral hemorrhage. Neurology. 2017;88(23):2169-2175. Available from: https://doi.org/10.1212/WNL.0000000000004009. Go to original source... Go to PubMed...
    36. Lamberink HJ, Otte WM, Geerts AT, et al. Individualised prediction model of seizure recurrence and long­‑term outcomes after withdrawal of antiepileptic drugs in seizure­‑free patients: a systematic review and individual participant data meta­‑analysis. The Lancet. Neurology. 2017;16(7):523531. Available from: https://doi.org/10.1016/S1474-4422(17)30114-X. Go to original source... Go to PubMed...
    37. Mauritz M, Hirsch JL, Camfield P, et al. Acute symptomatic seizures: an educational, evidence­‑based review. Epileptic Disorders. 2022;24(1):26-49. Available from: https://doi.org/10.1684/epd.2021.1376. Go to original source... Go to PubMed...
    38. Mecarelli O. Clinical Electroencephalography. Springer. 2019. Go to original source...
    39. Okuda S, Takano S, Ueno M, et al. Clinical features of late­‑onset poststroke seizures', Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association. 2012;21(7):583-586. Available from: https://doi.org/10.1016/j.jstrokecerebrovasdis.2011. 01. 006. Go to original source... Go to PubMed...
    40. Scoppettuolo P, Gaspard N, Depondt C, et al. Epileptic activity in neurological deterioration after ischemic stroke, a continuous EEG study', Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology. 2019;130(12):2282-2286. Available from: https://doi.org/10.1016/j.clinph.2019. 09. 005. Go to original source...
    41. Serafini A, Gigli GL, Gregoraci G, et al. Are Early Seizures Predictive of Epilepsy after a Stroke? Results of a Population­‑Based Study. Neuroepidemiology. 2015;45(1):50-58. Available from: https://doi.org/10.1159/000382078. Go to original source... Go to PubMed...
    42. Sheth KN, Martini SR, Moomaw CHJ, et al. Prophylactic Antiepileptic Drug Use and Outcome in the Ethnic/Racial Variations of Intracerebral Hemorrhage Study. Stroke. 2015;46(12):3532-3535. Available from: https://doi.org/10.1161/STROKEAHA.115.010875. Go to original source... Go to PubMed...
    43. So EL, Annegers JF, Hauser WA, et al. Population­‑based study of seizure disorders after cerebral infarction. Neurology. 1996;46(2):350-355. Available from: https://doi.org/10.1212/wnl.46. 2. 350. Go to original source... Go to PubMed...
    44. Talaat FM, Kamel T, Rabah AM, et al. Epilepsy and antiepileptic drugs: risk factors for atherosclerosis', The International Journal of Neuroscience. 2015;125(7):507-511. Available from: https://doi.org/10.3109/00207454.2014.949704. Go to original source... Go to PubMed...
    45. Tanaka T, Ihara M. Post­‑stroke epilepsy. Neurochemistry International. 2017;107_219-228. Available from: https://doi.org/10.1016/j.neuint.2017. 02. 002. Go to original source... Go to PubMed...
    46. Trinka E, Brigo F. Antiepileptogenesis in humans: disappointing clinical evidence and ways to move forward. Current Opinion in Neurology. 2014;27(2):227-235. Available from: https://doi.org/10.1097/WCO.0000000000000067. Go to original source... Go to PubMed...
    47. Verrotti A, Manco R, Agostinelli S, et al. The metabolic syndrome in overweight epileptic patients treated with valproic acid. Epilepsia. 2010;51(2):268-273. Available from: https://doi.org/10.1111/j.1528-1167.2009.02206.x. Go to original source... Go to PubMed...
    48. Vitturi BK, Gagliardi RJ. The influence of statins on the risk of post­‑stroke epilepsy', Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2020;41(7):1851-1857. Available from: https://doi.org/10.1007/s10072-020-04298-5. Go to original source... Go to PubMed...
    49. Wagner F, et al. Post­‑stroke epilepsy: does stroke volume matter?. 2011:46-46.
    50. Wang JZ, Manav VV, Saposnik G, et al. Incidence and management of seizures after ischemic stroke: Systematic review and meta­‑analysis. Neurology. 2017;89(12):1220-1228. Available from: https://doi.org/10.1212/WNL.0000000000004407. Go to original source... Go to PubMed...
    51. Witsch J, Frey HP, Schmidt JM, et al. Electroencephalographic Periodic Discharges and Frequency­‑Dependent Brain Tissue Hypoxia in Acute Brain Injury. JAMA Neurology. 2017;74(3):301-309. Available from: https://doi.org/10.1001/jamaneurol.2016.5325. Go to original source... Go to PubMed...
    52. Yiş U, Doğan M. Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children. Brain & Development. 2012;34(3):185-188. Available from: https://doi.org/10.1016/j.braindev.2011. 05. 009. Go to original source... Go to PubMed...
    53. Zelano J, Redfors P, Asberg S, et al. Association between poststroke epilepsy and death: A nationwide cohort study. European Stroke Journal. 2016;1(4):272-278. Available from: https://doi.org/10.1177/2396987316669000. Go to original source... Go to PubMed...
    54. Zelano J, Holtkamp M, Agarwal N, et al. How to diagnose and treat post­‑stroke seizures and epilepsy', Epileptic Disorders: International Epilepsy Journal with Videotape. 2010;22(3):252-263. Available from: https://doi.org/10.1684/epd.2020.1159. Go to original source... Go to PubMed...
    55. Zeng K, Wang X, Xi Z, et al. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Clinical Neurology and Neurosurgery. 2010;112(4):291-295. Available at: https://doi.org/10.1016/j.clineuro.2009. 12. 014. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.